Back to Search
Start Over
Nano-trapping CXCL13 reduces regulatory B cells in tumor microenvironment and inhibits tumor growth.
- Source :
-
Journal of Controlled Release . Mar2022, Vol. 343, p303-313. 11p. - Publication Year :
- 2022
-
Abstract
- Interactions between different cell types in the tumor microenvironment (TME) affect tumor growth. Tumor-associated fibroblasts produce C-X-C motif chemokine ligand 13 (CXCL13) which recruits B cells to the TME. B-cells in the TME differentiate into regulatory B cells (Bregs) (IL-10+CD1d+CD5+CD138+CD19+). We highlight these Breg cells as a new important factor in the modulation of the immunosuppressive TME in different desmoplastic murine tumor models. In addition, CXCL13 also stimulates epithelial–mesenchymal transition (EMT) of the tumor cells. The tumorigenic roles of CXCL13 led us to explore an innovative anti-cancer strategy based on delivering plasmid DNA encoding a CXCL13 trap to reduce Bregs differentiation and normalize EMT, thereby suppressing tumor growth. CXCL13 trap suppressed tumor growth in pancreatic cancer, BRAF-mutant melanoma, and triple-negative breast cancer. In this study, following treatment, the affected tumor remained dormant resulting in prolonged progression-free survival of the host. [Display omitted] • Chemokine CXCL13 recruits B cells to the tumor microenvironment (TME), where they differentiate into regulatory B cells (Bregs). • We highlight these Breg cells as a new key element in controlling the immunosuppressive TME in different desmoplastic murine tumor models. • The tumorigenic roles of CXCL13 led us to explore an innovative anti-cancer strategy trap to reduce Bregs differentiation and normalize EMT. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01683659
- Volume :
- 343
- Database :
- Academic Search Index
- Journal :
- Journal of Controlled Release
- Publication Type :
- Academic Journal
- Accession number :
- 155940397
- Full Text :
- https://doi.org/10.1016/j.jconrel.2022.01.039